Clinical Trial Update: Safety of NGOIS Compared to BSS Plus in Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety of NGOIS versus BSS Plus in pediatric cataract patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• BSS PLUS (BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE)
• NGOIS

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 3 | Status: COMPLETED